Asia · Financial press · The Economic Times

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

Published by The Economic Times · India 4 h ago

Sun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Revenue grew 11.8%, supported by strong…

Read the full article on The Economic Times Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (economictimes.indiatimes.com)

Also worth reading

Caixin Global

China’s Communist Party Fills 10 Central Committee Vacancies

SCMP Business

Amid brutal sell-off, what comes next for Google, Amazon and other Big Tech titans?

Nikkei Asia

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

Share

Also worth reading

China’s Communist Party Fills 10 Central Committee Vacancies

Amid brutal sell-off, what comes next for Google, Amazon and other Big Tech titans?

Uniqlo shakes up China strategy with focus on store profitability